Mahbod

Reaching Renal Replacement Therapy Targets Through Quality Improvement Initiatives: A Success Story

January 16, 2020 // 0 Comments

Acute kidney injury (AKI) is common in hospitalized patients and is associated with high morbidity and mortality, especially if requiring renal replacement therapy. Continuous renal replacement therapy (CRRT) is indicated in patients who are [read more...]

Predicting Polyuria: Can We Help Patients with ADPKD Better Tolerate Tolvaptan?

May 6, 2019 // 0 Comments

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, often results in the need for renal replacement therapy, and is the etiology for renal failure in 10% of dialysis patients. Few treatment options [read more...]

Portable and Implantable Artificial Kidneys: AWAK, WAK, and IAK, oh my!

October 11, 2018 // 2 Comments

Kidney disease carries a high burden for individual patients and for the medical system as a whole. End-stage kidney disease (ESKD) is associated with high mortality and decreased quality of life for many reasons including residual symptoms, pill [read more...]

#NephMadness 2018: Women’s Health Region

March 15, 2018 // 1 Comment

Submit your picks! | NephMadness 2018 | #NephMadness | #WomensHealthRegion “It is said you are never defeated unless you give up. We’re not going to give up.” – Pat Summitt, the all-time winningest coach in NCAA basketball [read more...]

AJKD Blog

Official Blog of the American Journal of Kidney Diseases

Mahbod

Reaching Renal Replacement Therapy Targets Through Quality Improvement Initiatives: A Success Story

Predicting Polyuria: Can We Help Patients with ADPKD Better Tolerate Tolvaptan?

Portable and Implantable Artificial Kidneys: AWAK, WAK, and IAK, oh my!

#NephMadness 2018: Women’s Health Region